Sun Pharma Agrees Not To Sell Generics Of Sleep Aid Lunesta

Law360, New York (April 5, 2013, 3:40 PM EDT) -- A New Jersey federal judge approved a final settlement Thursday in Sunovion Pharmaceuticals Inc.’s patent infringement suit against Sun Pharma Global Inc. over its sleep aid drug Lunesta, a deal that bars Sun Pharma from making or selling a generic version of Lunesta before April 2014.

U.S. District Judge Susan D. Wigenton signed off on the consent judgment and order of permanent injunction between the parties in which Sun Pharma and its subsidiaries Sun Pharmaceutical Industries Inc. and Sun Pharmaceutical Industries Ltd. agreed to put off...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.